Article

| CRISPR Medicine | This is an overview of all our articles

CMN Weekly (19 December 2025) - Your Weekly CRISPR...

CMN Weekly

Dec. 19, 2025

Some of the best links we picked up around the internet

nChroma Bio clears first clinical hurdle for...

CMN Clinical

Dec. 17, 2025

nChroma Bio has received regulatory clearance in Hong Kong to initiate a Phase 1/2 clinical trial of its lead candidate CRMA-1001, marking the first...

Cas5 dimer structure offers clues for CRISPR...

CMN Briefs

Dec. 15, 2025

Structural analysis of Cas5 from Moraxella bovoculi reveals that this protein functions equally well as a monomer or a dimer for RNA processing, but...

CMN Weekly (12 December 2025) - Your Weekly CRISPR...

CMN Weekly

Dec. 12, 2025

Some of the best links we picked up around the internet

Researchers engineer programmable gene activation...

CMN Special

Dec. 10, 2025

A redesigned CRISPR guide RNA system can now switch on multiple human genes in a fixed order, mimicking the staged logic of cell differentiation. The...

CMN Weekly (5 December 2025) - Your Weekly CRISPR...

CMN Weekly

Dec. 5, 2025

Some of the best links we picked up around the internet

Screening identifies improved Cas9 for precise...

CMN Briefs

Dec. 3, 2025

Japanese researchers have developed a screening system using diphtheria toxin resistance to identify CRISPR-Cas9 variants with enhanced...

Regeneron and Tessera advance TSRA-196 toward...

CMN Clinical

Dec. 1, 2025

Regeneron Pharmaceuticals and Tessera Therapeutics have formed a global partnership to develop and commercialise TSRA-196, Tessera’s lead in vivo Gene...